Vertex Pharmaceuticals Stock Soaring: Is More Upside Ahead?
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
Knowing when to switch from passive to active strategies can boost returns. This guide outlines practical signals, costs, and risk considerations.
27,240 articlesVertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
A volatile day in the stock market today, july features a notable drop for Eos Energy after project news. Learn what ...
Trump appears set to scrap the memorandum of understanding with Iran, yet U.S. markets are largely muted as traders f...
Bloom Energy has climbed about 160% ytd, powered by a surge in AI-related data-center demand and new partnerships. Th...
A new Goldman Sachs note argues that AI’s next growth wave hinges on optical networking, not just faster GPUs. Lument...
In 2026, property owners are selling experiences, not just space. Lenders are adjusting terms as tenants sign leases ...
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
Binance celebrates its ninth year with rapid user growth and a bold move into traditional financial services. The com...
Amazon's cloud unit, AWS, stands as a pillar of the company's profitability. This article breaks down the cloud growt...
When a board member sells 7,000 shares, traders and long-term investors want to know why. This article breaks down Fo...
BYD’s Q2 2026 results set a new pace for electric vehicles, with a headline figure of 557,090 BEVs. This shift challe...
A massive compute deal rumor could redraw the AI cloud map. This article explains what the potential billion compute ...